Thymosin Alpha-1 matched spec perfectly
We run cytokine arrays alongside Thymosin Alpha-1 experiments. This lot produced the expected pattern with zero anomalies. Third-party COA verified our results. Excellent supplier.
Thymosin Alpha-1 (Ta1) is a 28-amino acid thymic peptide approved in 35+ countries (as Zadaxin) for hepatitis and immunodeficiency. It is studied for T-cell modulation, innate immune priming, and anti-tumour activity.
| Format | Lyophilized Vial |
|---|---|
| Dosage | 5mg |
| Purity | >98% |
| Sub-Line | REGENERIS |
In Stock — Overnight and 2–3 day delivery available
Thymosin Alpha-1 (Ta1) is a 28-amino acid N-acetylated peptide naturally secreted by thymic epithelial cells. It is the best-characterised component of Thymosin Fraction 5 and is approved as Zadaxin in over 35 countries for chronic hepatitis B and C, and as an adjunct in immunodeficiency states.
Ta1 has been studied in chronic viral hepatitis, cancer immunology, sepsis, COVID-19 adjunct immunotherapy, and ageing-related immunosenescence. Extensive Phase II/III clinical data is available via the Zadaxin approval record.
For Research Use Only. Rainbow Peptide supplies Thymosin Alpha-1 exclusively for in vitro and laboratory research purposes. Not for human or veterinary use.
Third-Party Verified
We don't just claim purity — we prove it. Every batch of Thymosin Alpha-1 is independently tested by an accredited third-party laboratory before it reaches you. Your COA is linked to your specific lot number.
Verified purchases from active research labs and scientists
We run cytokine arrays alongside Thymosin Alpha-1 experiments. This lot produced the expected pattern with zero anomalies. Third-party COA verified our results. Excellent supplier.
KPV lot tested at 98.7% HPLC. Clean mass spectrum, appropriate molecular weight confirmed. COA matched. Highly recommend for immunomodulatory research.
On our fourth order. Each batch has had consistent purity. Support proactively sent documentation clarifying storage conditions. Excellent service.